drugset / Trial / NCT05677126

Tralement vs. Fixed-dose Trace Element Combination Product in Patients >3 to 17 Years of Age Requiring Long-term PN

NCT05677126

Phase 4 Withdrawn American Regent, Inc.
RandomizedParallel-groupTriple-blindTreatment

Summary

Tralement versus a fixed-dose trace element combination product of zinc, copper, and selenious acid to evaluate product safety in pediatric patients \>3 to 17 years of age requiring long-term parenteral nutrition.

Timeline

Start
2024-08
Primary completion
2024-08
Completion
2024-08-26

Drugs

EvaluationDrugModalityDoseRoute
Comparator Tralement Unknown
Comparator Copper Unknown
Comparator Zinc Sulfate Unknown
Comparator selenious acid Unknown

Indications

No indication recorded.